Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation Reduction Act (IRA) was passed.

A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at 3-year follow-up among patients undergoing CABG surgery.

A scientific statement has been published by the American Heart Association regarding the effect of sleep health on cardiometabolic health.

HealthDay News — More U.S. children have died from the flu this season than in any year since the 2009 swine flu pandemic, according to a new federal report.

HHS and the NIH announced "Generation Gold Standard," an initiative to develop next-generation, universal vaccines.

HealthDay News — For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes, according to a study ...

A well-known US science journal focused on environmental health has stopped accepting new studies, raising alarms among researchers who rely on it heavily.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Dr Marty Makary opened up about his first weeks on the job as FDA commissioner and his vision for the future of the agency.